| Assessment Status | Assessment process complete |
| HTA ID | - |
| Drug | Hyaluronic acid and co enzyme Q10 |
| Brand | VisuXL® |
| Indication | For the treatment of dry eye disease and the treatment of post-surgical intervention following elective surgery and trauma. |
| Assessment Process | |
| Rapid review commissioned | 06/11/2017 |
| Rapid review completed | 30/11/2017 |
| Rapid review outcome | Reimbursement not recommended at the submitted price. |